Holdings (39)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 11.17% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 7.19% |
| Cipla Ltd. | Healthcare | Equity | 5.76% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 5.58% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 5.44% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 5.3% |
| Lupin Ltd. | Healthcare | Equity | 4.58% |
| Aster DM Healthcare Ltd. | Healthcare | Equity | 4.45% |
| Wockhardt Ltd. | Healthcare | Equity | 3.67% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 2.9% |
Returns and rankings
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund Returns | 6.96% | 25.07% | 21.47% | 9.22% |
| Category Average | 9.84% | 23.72% | 19.61% | NA% |
| Rank Within Category | 10.00% | 3.00% | 3.00% | NA% |
Expense ratio, exit load and tax
Expense ratio: 0.61%
Inclusive of GST
Exit load
Exit load of 0.25% if redeemed within 30 days.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Fund management
Education
Mr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad
Experience
Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services